Tech Company Financing Transactions

Synlogic Funding Round

Synlogic secured a $40 million Series B financing round on 2/17/2016. Backers included Atlas Venture, OrbiMed and Deerfield Capital.

Transaction Overview

Company Name
Synlogic
Announced On
2/17/2016
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series B
Investors

Atlas Venture (Lead Investor) (Peter Barrett)

OrbiMed (Lead Investor) (Chau Khuong)

Deerfield Capital

New Enterprise Associates (Ed Mathers)

Proceeds Purpose
The additional funds will support the development efforts of our two lead inborn errors of metabolism programs, UCD and PKU, which we plan to advance to the clinic in early 2017, as well as expand our pipeline of Synthetic Biotics across multiple therapeutic areas. This financing together with our recently announced partnership with AbbVie for the treatment of inflammatory bowel diseases, positions Synlogic well to realize the transformative potential of this new class of medicines.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
301 Binney St. 402
Cambridge, MA 02142
USA
Phone
(617) 401-9975
Website
www.synlogictx.com
Email Address
[email protected]
Overview
Synlogic leverages the most advanced technology platform available for the creation of synthetically engineered, therapeutic microbes with the potential to make significant advancements in the treatment of disease.
Profile
Synlogic LinkedIn Company Profile
Social Media
Synlogic Company Twitter Account
Company News
Synlogic News
Facebook
Synlogic on Facebook
YouTube
Synlogic on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Aoife Brennan
  Aoife Brennan LinkedIn Profile  Aoife Brennan Twitter Account  Aoife Brennan News  Aoife Brennan on Facebook
Chief Financial Officer
Todd Shegog
  Todd Shegog LinkedIn Profile  Todd Shegog Twitter Account  Todd Shegog News  Todd Shegog on Facebook
Chief Scientific Officer
Scott Plevy
  Scott Plevy LinkedIn Profile  Scott Plevy Twitter Account  Scott Plevy News  Scott Plevy on Facebook
VP - General Counsel
Maiken Keson-Brookes
  Maiken Keson-Brookes LinkedIn Profile  Maiken Keson-Brookes Twitter Account  Maiken Keson-Brookes News  Maiken Keson-Brookes on Facebook
VP - Human Resources
Adam Thomas
  Adam Thomas LinkedIn Profile  Adam Thomas Twitter Account  Adam Thomas News  Adam Thomas on Facebook
VP - Operations
Antoine Awad
  Antoine Awad LinkedIn Profile  Antoine Awad Twitter Account  Antoine Awad News  Antoine Awad on Facebook
VP - Product Management
Caroline Kurtz
  Caroline Kurtz LinkedIn Profile  Caroline Kurtz Twitter Account  Caroline Kurtz News  Caroline Kurtz on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/17/2016: Sprout Social venture capital transaction
Next: 2/17/2016: Knewton venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.